DIGINEX LTD (DGNX) Fundamental Analysis & Valuation

NASDAQ:DGNX • KYG286871044

Current stock price

1.955 USD
+0.14 (+7.42%)
At close:
1.9597 USD
+0 (+0.24%)
After Hours:

This DGNX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DGNX Profitability Analysis

1.1 Basic Checks

  • DGNX had negative earnings in the past year.
  • In the past year DGNX has reported a negative cash flow from operations.
DGNX Yearly Net Income VS EBIT VS OCF VS FCFDGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • DGNX has a Return On Assets of -73.04%. This is amonst the worse of the industry: DGNX underperforms 90.07% of its industry peers.
  • Looking at the Return On Equity, with a value of -101.26%, DGNX is doing worse than 80.51% of the companies in the same industry.
Industry RankSector Rank
ROA -73.04%
ROE -101.26%
ROIC N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DGNX Yearly ROA, ROE, ROICDGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • DGNX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DGNX Yearly Profit, Operating, Gross MarginsDGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 -200 -400 -600 -800 -1K

6

2. DGNX Health Analysis

2.1 Basic Checks

  • DGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DGNX has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for DGNX has been reduced compared to a year ago.
DGNX Yearly Shares OutstandingDGNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
DGNX Yearly Total Debt VS Total AssetsDGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • DGNX has an Altman-Z score of 54.34. This indicates that DGNX is financially healthy and has little risk of bankruptcy at the moment.
  • DGNX has a better Altman-Z score (54.34) than 98.53% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that DGNX is not too dependend on debt financing.
  • DGNX has a better Debt to Equity ratio (0.00) than 65.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 54.34
ROIC/WACCN/A
WACC10.88%
DGNX Yearly LT Debt VS Equity VS FCFDGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 3.56 indicates that DGNX has no problem at all paying its short term obligations.
  • DGNX has a Current ratio of 3.56. This is in the better half of the industry: DGNX outperforms 77.57% of its industry peers.
  • A Quick Ratio of 3.56 indicates that DGNX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.56, DGNX is in the better half of the industry, outperforming 77.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 3.56
DGNX Yearly Current Assets VS Current LiabilitesDGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M

3

3. DGNX Growth Analysis

3.1 Past

  • The earnings per share for DGNX have decreased strongly by -75.98% in the last year.
  • The Revenue has grown by 124.47% in the past year. This is a very strong growth!
  • Measured over the past years, DGNX shows a very strong growth in Revenue. The Revenue has been growing by 22.13% on average per year.
EPS 1Y (TTM)-75.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.44%
Revenue 1Y (TTM)124.47%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%292.74%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DGNX Yearly Revenue VS EstimatesDGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 500K 1M 1.5M 2M

0

4. DGNX Valuation Analysis

4.1 Price/Earnings Ratio

  • DGNX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DGNX Price Earnings VS Forward Price EarningsDGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DGNX Per share dataDGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. DGNX Dividend Analysis

5.1 Amount

  • DGNX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DGNX Fundamentals: All Metrics, Ratios and Statistics

DIGINEX LTD

NASDAQ:DGNX (5/1/2026, 8:21:49 PM)

After market: 1.9597 +0 (+0.24%)

1.955

+0.14 (+7.42%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)12-09
Earnings (Next)N/A
Inst Owners0.35%
Inst Owner ChangeN/A
Ins Owners2.25%
Ins Owner Change0%
Market Cap454.65M
Revenue(TTM)4.09M
Net Income(TTM)-11.02M
AnalystsN/A
Price TargetN/A
Short Float %2.99%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 111.27
P/FCF N/A
P/OCF N/A
P/B 41.78
P/tB 41.78
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -73.04%
ROE -101.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-388.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 3.56
Altman-Z 54.34
F-Score5
WACC10.88%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-373.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)124.47%
Revenue growth 3Y22.13%
Revenue growth 5YN/A
Sales Q2Q%292.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.98%
OCF growth 3YN/A
OCF growth 5YN/A

DIGINEX LTD / DGNX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIGINEX LTD?

ChartMill assigns a fundamental rating of 2 / 10 to DGNX.


What is the valuation status for DGNX stock?

ChartMill assigns a valuation rating of 0 / 10 to DIGINEX LTD (DGNX). This can be considered as Overvalued.


How profitable is DIGINEX LTD (DGNX) stock?

DIGINEX LTD (DGNX) has a profitability rating of 0 / 10.


What is the financial health of DIGINEX LTD (DGNX) stock?

The financial health rating of DIGINEX LTD (DGNX) is 6 / 10.